| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Oct 15, 2024 | Oct 17, 2024 | Upstream Bio, Inc. | Director | Buy | 100.0 | +825,000 | 16.95% | ✗ | $14M |
| May 15, 2024 | May 20, 2024 | BiomX Inc. | 10% Owner | Sell | 52.5 | -24,344 | -0.18% | ✗ | $9.3K |
| Jun 27, 2023 | Jun 29, 2023 | Adicet Bio, Inc. | Director | Buy | 100.0 | +875,000 | 12.10% | ✗ | $1.8M |
| Feb 27, 2023 | Mar 17, 2023 | BiomX Inc. | 10% Owner | Buy | 95.0 | +348,000 | 12.37% | ✗ | $85.3K |
| Dec 18, 2019 | Dec 20, 2019 | BiomX Inc. | Director | Buy | 56.3 | +4,000 | 0.17% | ✗ | $35.6K |
| Dec 10, 2019 | Dec 12, 2019 | BiomX Inc. | Director | Buy | 65.0 | +8,800 | 0.38% | ✗ | $77.9K |
| Dec 5, 2019 | Dec 9, 2019 | BiomX Inc. | Director | Buy | 65.0 | +10,200 | 0.45% | ✗ | $85.6K |
| May 2, 2019 | May 6, 2019 | Eledon Pharmaceuticals, Inc. | Director | Buy | 100.0 | +646,204 | 25.47% | ✗ | $2M |